Consortium for Tobacco Use Cessation Technical Assistance

Dates:
 Informational conference calls: CDC will conduct two conference calls for all interested applicants to provide technical assistance and respond to any questions regarding this Funding Opportunity Announcement (FOA). The calls will take place on June 26, 2013 at 10:00am and 3:00 pm, U.S. Eastern Standard Time. The dial-in information is: 1-888-609-7382; Passcode: 36742490. The calls will be recorded. Instructions for accessing the recording and a list of Frequently Asked Questions will be available at: http://www.cdc.gov/tobacco/osh/foa/consortium/.
 Letter of Intent Deadline Date: June 28, 2013
 Application Deadline Date: July 15, 2013, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov
Tobacco use remains the leading preventable cause of disease and death in the United States. More than half of smokers attempt to quit each year, but only 4-7% succeed. Evidence-based cessation treatments, including individual, group, and telephone counseling and seven FDA-approved cessation medications, exist, but are underutilized. Cessation interventions by health care providers increase quit rates, but many health care providers do not routinely intervene with their patients who use tobacco products. The Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health proposes a
competitive, non-research Funding Opportunity Announcement to seek applicants to develop a consortium for tobacco use cessation technical assistance. The aim of the cessation consortium is to provide technical assistance to state tobacco control programs and national and state partners by translating the science of tobacco control cessation into public health action which increases the number of tobacco users who quit. Specifically, the consortium is intended to provide technical assistance to state tobacco control programs and national and state partners to support their efforts to (1) enhance state quitline capacity and sustainability and (2) promote comprehensive private and public insurance coverage of cessation treatments and promote health systems change to integrate tobacco dependence treatment into the clinical workflow.

READ MORE HERE